Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

An Advanced Pharmacy Practice Experience for Community Pharmacies Based on a Clinical Intervention Targeting Patients With Inflammatory Bowel Disease.

Blackburn DF, Fowler S, Crawley A, Gerwing S, Alcorn J, Mansell H, Evans C, Mansell K, Taylor J, Jorgenson D, Larocque D, Rotter T, Shevchuk Y.

J Pharm Pract. 2019 Jun 25:897190019857410. doi: 10.1177/0897190019857410. [Epub ahead of print]

PMID:
31238777
2.

Community pharmacists' experiences with the Saskatchewan Medication Assessment Program.

Currie K, Evans C, Mansell K, Perepelkin J, Jorgenson D.

Can Pharm J (Ott). 2019 Feb 27;152(3):193-203. doi: 10.1177/1715163519827980. eCollection 2019 May-Jun.

3.

Impact of pharmacist-led medication assessments on medication costs.

Jorgenson D, Landry E, Lysak K, Bhimji H.

Can Pharm J (Ott). 2018 Dec 12;152(1):23-27. doi: 10.1177/1715163518815211. eCollection 2019 Jan-Feb. No abstract available.

4.

Vitamin and mineral supplement use in medically complex, community-living, older adults.

Ford KL, Jorgenson DJ, Landry EJL, Whiting SJ.

Appl Physiol Nutr Metab. 2019 Apr;44(4):450-453. doi: 10.1139/apnm-2018-0515. Epub 2019 Jan 10.

5.

Student perceptions of an experiential education clinic within a pharmacy school.

Lysak K, Berenbaum SL, Landry EJ, Mulhall SM, Perepelkin JP, Shevchuk YM, Taylor JG, Jorgenson DJ.

Curr Pharm Teach Learn. 2018 Dec;10(12):1636-1640. doi: 10.1016/j.cptl.2018.09.001. Epub 2018 Sep 12.

PMID:
30527831
6.

Is it time for internal medicine pharmacists in primary care?

Jorgenson D.

Can Pharm J (Ott). 2018 Jun 1;151(4):214-216. doi: 10.1177/1715163518779344. eCollection 2018 Jul-Aug. No abstract available.

7.

Strategy to Address Private Location Cardiac Arrest: A Public Safety Survey.

Blackwood J, Eisenberg M, Jorgenson D, Nania J, Howard B, Collins B, Connell P, Day T, Rohrbach C, Rea T.

Prehosp Emerg Care. 2018 Nov-Dec;22(6):784-787. doi: 10.1080/10903127.2018.1462419. Epub 2018 May 16.

PMID:
29768077
8.

Family physician perceptions of a medication assessment clinic located within a pharmacy school.

Jorgenson DJ, Landry EJL, Lysak KJ.

Can Fam Physician. 2017 Dec;63(12):e512-e517.

9.

Part 3: Perspectives of pharmacy technicians on practice change.

MacKinnon NJ, Penm J, Jorgenson D, Smith J.

Can Pharm J (Ott). 2017 Jul 7;150(4):239-242. doi: 10.1177/1715163517713201. eCollection 2017 Jul-Aug. No abstract available.

10.

Part 5: Future vision for the pharmacy profession.

Jorgenson D, Penm J, MacKinnon NJ, Smith J.

Can Pharm J (Ott). 2017 Oct 5;150(6):355-358. doi: 10.1177/1715163517734156. eCollection 2017 Nov-Dec. No abstract available.

11.

Statewide data infrastructure supports population health management: diabetes case study.

Jones C, Mohlman MK, Jorgenson D, Finison K, McGee K, Kastensmith H.

Am J Manag Care. 2017 Oct 1;23(10):e331-e339.

12.

Part 4: Professional satisfaction and the priorities to advance the pharmacy profession.

MacKinnon NJ, Jorgenson D, Penm J, Smith J.

Can Pharm J (Ott). 2017 Aug 10;150(5):282-284. doi: 10.1177/1715163517713443. eCollection 2017 Sep-Oct. No abstract available.

13.

Part 2: Roles and expertise needed to move the profession forward and improve health outcomes.

Penm J, MacKinnon NJ, Jorgenson D, Smith J.

Can Pharm J (Ott). 2017 Apr 7;150(3):153-155. doi: 10.1177/1715163517702378. eCollection 2017 May-Jun. No abstract available.

14.

Part 1: Barriers to the advancement of the pharmacy profession.

Penm J, Jorgenson D, MacKinnon NJ, Smith J.

Can Pharm J (Ott). 2017 Apr 7;150(3):150-152. doi: 10.1177/1715163517702377. eCollection 2017 May-Jun. No abstract available.

15.

Risk-adjustment methods for all-payer comparative performance reporting in Vermont.

Finison K, Mohlman M, Jones C, Pinette M, Jorgenson D, Kinner A, Tremblay T, Gottlieb D.

BMC Health Serv Res. 2017 Jan 19;17(1):58. doi: 10.1186/s12913-017-2010-0.

16.

Need for Formal Specialization in Pharmacy in Canada: A Survey of Hospital Pharmacists.

Penm J, MacKinnon NJ, Jorgenson D, Ying J, Smith J.

Can J Hosp Pharm. 2016 Sep-Oct;69(5):356-366. Epub 2016 Oct 31.

17.

Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.

Blackburn DF, Evans CD, Eurich DT, Mansell KD, Jorgenson DJ, Taylor JG, Semchuk WM, Shevchuk YM, Remillard AJ, Tran DA, Champagne AP.

Pharmacotherapy. 2016 Oct;36(10):1055-1064. doi: 10.1002/phar.1831. Epub 2016 Sep 25.

PMID:
27581815
18.

A needs assessment of community pharmacists for pharmacist specialization in Canada.

Jorgenson D, Penm J, MacKinnon N, Smith J.

Int J Pharm Pract. 2017 Apr;25(2):159-167. doi: 10.1111/ijpp.12297. Epub 2016 Aug 4.

PMID:
27488476
19.

A comparison of drug therapy problems in patients eligible and ineligible for provincial medication review programs in Canada.

Pammett R, Jorgenson D.

Can Pharm J (Ott). 2016 May;149(3):125-9. doi: 10.1177/1715163516640295. Epub 2016 Mar 29. No abstract available.

20.

A mixed methods evaluation of a patient care clinic located within a pharmacy school.

Jorgenson DJ, Landry EJ, Lysak KJ.

Int J Clin Pharm. 2016 Aug;38(4):924-30. doi: 10.1007/s11096-016-0313-6. Epub 2016 May 11.

PMID:
27166829
21.

Evaluation of a Community Pharmacy-Based Screening Questionnaire to Identify Patients at Risk for Drug Therapy Problems.

Pammett RT, Blackburn D, Taylor J, Mansell K, Kwan D, Papoushek C, Jorgenson D.

Pharmacotherapy. 2015 Sep;35(9):881-6. doi: 10.1002/phar.1633.

PMID:
26406776
22.

Carotid Doppler blood flow measurement during cardiopulmonary resuscitation is feasible: A first in man study.

Adedipe AA, Fly DL, Schwitz SD, Jorgenson DB, Duric H, Sayre MR, Nichol G.

Resuscitation. 2015 Nov;96:121-5. doi: 10.1016/j.resuscitation.2015.07.024. Epub 2015 Jul 30.

PMID:
26234896
23.

Participation in online continuing education.

Farrell B, Ward N, Jennings B, Jones C, Jorgenson D, Gubbels-Smith A, Dolovich L, Kennie N.

Int J Pharm Pract. 2016 Feb;24(1):60-71. doi: 10.1111/ijpp.12202. Epub 2015 Jul 15.

PMID:
26173959
24.

Interprofessional student-run primary health care clinics: Implications for pharmacy education in Scotland.

Weidmann AE, Pammett R, Landry E, Jorgenson D.

Can Pharm J (Ott). 2015 May;148(3):156-9. doi: 10.1177/1715163515578124.

25.

Interprofessional student-run primary health care clinics: Educational experiences for pharmacy students.

Pammett R, Landry E, Weidmann AE, Jorgenson D.

Can Pharm J (Ott). 2015 May;148(3):125-8. doi: 10.1177/1715163515578123. No abstract available.

26.

A course-based cross-cultural interaction among pharmacy students in Qatar and Canada.

Wilby KJ, Taylor J, Khalifa SI, Jorgenson D.

Am J Pharm Educ. 2015 Mar 25;79(2):26. doi: 10.5688/ajpe79226.

27.

Response to letter regarding article, "waveform analysis-guided treatment versus a standard shock-first protocol for the treatment of out-of-hospital cardiac arrest presenting in ventricular fibrillation: results of an international randomized, controlled trial".

Freese JP, Jorgenson DB, Liu PY, Innes J, Matallana L, Nammi K, Donohoe RT, Whitbread M, Silverman RA, Prezant DJ.

Circulation. 2014 Jun 10;129(23):e649. doi: 10.1161/CIRCULATIONAHA.114.009344. No abstract available.

PMID:
24914022
28.

Eligibility requirements for community pharmacy medication review services in Canada.

Pammett R, Jorgenson D.

Can Pharm J (Ott). 2014 Jan;147(1):20-4. doi: 10.1177/1715163513514006. No abstract available.

29.

Integrating pharmacists into primary care teams: barriers and facilitators.

Jorgenson D, Laubscher T, Lyons B, Palmer R.

Int J Pharm Pract. 2014 Aug;22(4):292-9. doi: 10.1111/ijpp.12080. Epub 2013 Nov 27.

PMID:
24279947
30.

Guidelines for pharmacists integrating into primary care teams.

Jorgenson D, Dalton D, Farrell B, Tsuyuki RT, Dolovich L.

Can Pharm J (Ott). 2013 Nov;146(6):342-52. doi: 10.1177/1715163513504528. No abstract available.

31.

Collaborative Cardiovascular Risk Reduction in Primary Care II (CCARP II): Implementation of a systematic case-finding process for patients with uncontrolled risk factors.

Yakiwchuk EM, Jorgenson D, Mansell K, Laubscher T, Lebras M, Blackburn DF.

Can Pharm J (Ott). 2013 Sep;146(5):284-92. doi: 10.1177/1715163513499303.

32.

Participatory health research: celebrating smoke-free homes.

Ramsden VR, McKay S, Bighead S, Boucher G, Bourassa C, Butt P, Clinton A, Crowe J, Felix F, Jorgenson D, LaRocque K, McKee N, Nketia I, Rabbitskin N, Thunderchild E, Troupe C, Turner T.

Can Fam Physician. 2013 Sep;59(9):1014-5.

33.

Waveform analysis-guided treatment versus a standard shock-first protocol for the treatment of out-of-hospital cardiac arrest presenting in ventricular fibrillation: results of an international randomized, controlled trial.

Freese JP, Jorgenson DB, Liu PY, Innes J, Matallana L, Nammi K, Donohoe RT, Whitbread M, Silverman RA, Prezant DJ.

Circulation. 2013 Aug 27;128(9):995-1002. doi: 10.1161/CIRCULATIONAHA.113.003273.

PMID:
23979627
34.

Characteristics of pharmacists who enrolled in the pilot ADAPT Education Program: Implications for practice change.

Jorgenson D, Gubbels-Smith A, Farrell B, Ward N, Dolovich L, Jennings B.

Can Pharm J (Ott). 2012 Nov;145(6):260-3. doi: 10.3821/145.6.cpj260. No abstract available.

35.

Integrating a brief pharmacist intervention into practice: Osteoporosis pharmacotherapy assessment.

Phillips L, Ferguson R, Diduck K, Lamb D, Jorgenson D.

Can Pharm J (Ott). 2012 Sep;145(5):218-20. doi: 10.3821/145.5.cpj218. No abstract available.

36.

Designing a novel continuing education program for pharmacists: Lessons learned.

Farrell B, Dolovich L, Emberley P, Gagné MA, Jennings B, Jorgenson D, Kennie N, Marks PZ, Papoushek C, Waite N, Woloschuk DM.

Can Pharm J (Ott). 2012 Jul;145(4):e7-e16. doi: 10.3821/145.4.cpje7. No abstract available.

37.

Appendix a: management committee terms of reference.

Farrell B, Dolovich L, Emberley P, Gagné MA, Jennings B, Jorgenson D, Kennie N, Marks PZ, Papoushek C, Waite N, Woloschuk DM.

Can Pharm J (Ott). 2012 Jul;145(4):A1-3. doi: 10.3821/145.4.cpjA1. No abstract available.

38.

Impacting sudden cardiac arrest in the home: a safety and effectiveness study of privately-owned AEDs.

Jorgenson DB, Yount TB, White RD, Liu PY, Eisenberg MS, Becker LB.

Resuscitation. 2013 Feb;84(2):149-53. doi: 10.1016/j.resuscitation.2012.09.033. Epub 2012 Oct 3.

PMID:
23041533
39.

Pharmacist educators in family medicine residency programs: a qualitative analysis.

Jorgenson D, Muller A, Whelan AM.

BMC Med Educ. 2012 Aug 11;12:74. doi: 10.1186/1472-6920-12-74.

40.

Pharmacist provision of primary health care: a modified Delphi validation of pharmacists' competencies.

Kennie-Kaulbach N, Farrell B, Ward N, Johnston S, Gubbels A, Eguale T, Dolovich L, Jorgenson D, Waite N, Winslade N.

BMC Fam Pract. 2012 Mar 28;13:27. doi: 10.1186/1471-2296-13-27.

41.

Proposing a redefinition of pharmaceutical care.

Blackburn DF, Yakiwchuk EM, Jorgenson DJ, Mansell KD.

Ann Pharmacother. 2012 Mar;46(3):447-9. doi: 10.1345/aph.1Q585. Epub 2012 Mar 6.

PMID:
22395251
42.

Pharmacists teaching in family medicine residency programs: National survey.

Jorgenson D, Muller A, Whelan AM, Buxton K.

Can Fam Physician. 2011 Sep;57(9):e341-6.

43.

Ocular side effects of bisphosphonates: A case report and literature review.

McKague M, Jorgenson D, Buxton KA.

Can Fam Physician. 2010 Oct;56(10):1015-7. Review. No abstract available.

44.
45.

The guidelines got it right on defibrillation energy protocol.

Russell JK, Jorgenson D, Fuller M.

Resuscitation. 2009 Dec;80(12):1438; author reply 1438-40. doi: 10.1016/j.resuscitation.2009.08.028. Epub 2009 Oct 17. No abstract available.

PMID:
19837502
46.

Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada.

Evans CD, Eurich DT, Lamb DA, Taylor JG, Jorgenson DJ, Semchuk WM, Mansell KD, Blackburn DF.

J Manag Care Pharm. 2009 Jul-Aug;15(6):476-84.

47.

Minimal interruption of cardiopulmonary resuscitation for a single shock as mandated by automated external defibrillations does not compromise outcomes in a porcine model of cardiac arrest and resuscitation.

Ristagno G, Tang W, Russell JK, Jorgenson D, Wang H, Sun S, Weil MH.

Crit Care Med. 2008 Nov;36(11):3048-53. doi: 10.1097/CCM.0b013e318186f612.

PMID:
18824916
48.

Examining asthma quality of care using a population-based approach.

Klomp H, Lawson JA, Cockcroft DW, Chan BT, Cascagnette P, Gander L, Jorgenson D.

CMAJ. 2008 Apr 8;178(8):1013-21. doi: 10.1503/cmaj.070426.

49.

Comparison of current densities measured in a pig heart during states of ventricular fibrillation and post-mortem for different defibrillation electrode positions.

DeMonte TP, Jorgenson DB, Wang D, Ma AW, Nachman AI, Joy MG.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:6301-4.

PMID:
17946367
50.

The quality of chest compressions during cardiopulmonary resuscitation overrides importance of timing of defibrillation.

Ristagno G, Tang W, Chang YT, Jorgenson DB, Russell JK, Huang L, Wang T, Sun S, Weil MH.

Chest. 2007 Jul;132(1):70-5. Epub 2007 Jun 5.

PMID:
17550931

Supplemental Content

Loading ...
Support Center